The symptoms of chin augmentation and correction include numbness and pain immediately after the procedure. The numbness is associated with the needle puncture nerves, whereas the discomfort is due to anesthesia complications and is of short duration.
Chin augmentation and correction is a well-established and a commonly practiced procedure. It is also relatively safe. The success rates are good, but the treatment is still not 'cured' and has a high likelihood of secondary procedures. Some of the side effects can also be severe. The main reason of secondary procedure is the recurrence of the problem and the desire to correct the problem by the more appropriate and advanced procedure.
Chin augmentation and correction can be considered as new cosmetic surgical procedures in the modern era under plastic surgery. Especially, the age of patients is increasing and as a result, facial aesthetics are an important matter nowadays. These 2 treatments can be carried out as one major operation or as multiple ones, and the best choice for individual cases should be determined according to the individual face and the particular type of chin augmentation or correction required.
Cheek augmentation and corrections are not uncommon among plastic and otorhinolaryngology surgeons. Multiple techniques exist and surgical correction is an option for mild cases. More severe cases may benefit from more permanent solutions such as osteotomies and bone grafts.
The chin is formed in the midface and it develops over time. Therefore, the appearance of the chin, by a person experiencing facial aging with skeletal growth, represents a different stage of ageing. Further research needs to look across more different facial and skeletal stages of aging in order to further elucidate chin anomalies. Nevertheless, in the present age, people with chin augmentation or the chin are experiencing an increase in psychological and physical dissatisfaction due to the change of facial appearance.
With the current technology available to us, most patients will receive some form of chin augmentation when they are older rather than undergoing chin augmentation surgery as a first-line treatment.
Younger people have a narrower interpupillary distance of less than the 75th percentile, which suggests narrower eyes, a narrower interpalpebral fissure, narrower canthi, and narrower palpebral fissure. The average age of first chin augmentation and correction in our practice is 31.48 ± 2.11 years. These and other objective measurements are commonly used when obtaining consent for chin augmentation and/or chin reconstruction. Many surgeons prefer to obtain a 3-dimensional CT scan to identify the patient's needs to avoid missing hidden canthi and fissures.
None of these developments, whether clinical or research, has addressed the specific patient-related issues which most impact satisfaction and overall outcome. The only new therapeutic approach has been the incorporation of tissue matching to the existing nasal-labial framework. Although this approach is the safest and most likely to produce the best results, it is not completely devoid of its own risks, particularly with the use of porous polyethylene implants. Future advances will hopefully address these issues. It remains to be seen whether all of this has made a difference in the satisfaction and outcome of patients with chin augmentation and correction.
The [Aedes aegypti] population density did not differ on average in both treatments, and the density in subjects with lower cheek augmentation and correction was slightly higher than that of the control group. This may affect [the efficacy of] [oral] diphtheria, [tetanus] toxoid, and [pneumococcal] vaccines.
Hyaluronic acid is known for promoting the repair of joint cartilage; however, its role in treating bone disorders is limited. We propose that HA, injected through a needle or catheter, may aid in the repair of non-union fractures and in relieving pain that can be associated with advanced stages of this condition.
The research on chin augmentation and correction is in an ambiguous and confusing environment. Patients often worry about the aesthetic outcome of the treatment, as well as potential side effects (such as pain and scarring) that could occur. It is hard to tell patients what is going to help in the future. There is a need to take further steps to reduce patient worry, improve communication of information to patients, and improve the quality of research and procedures. The main challenge for future research is to simplify, standardize, and develop the most effective techniques, and to address the many patient concerns and uncertainties related to chin augmentation and correction.
Hyaluronan can be used to treat the signs and symptoms of hyperhidrogenism including secondary facial changes (facial sweating and oily eyes but without lipoatrophy). When administered along with any current treatments, hyaluronan can significantly reduce signs and symptoms of hyperhidrosis and can be used as an alternative to surgery by reducing the need for surgery, minimizing the risk and discomfort associated with surgery, and decreasing surgery recovery time.